Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01429298 · ClinicalTrials.gov registry record · Phase 4
Comparing Intravenous Hydromorphone to Usual Care
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 350
- Enrollment target
NCT01429298 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 350 participants.
The verdict
NCT01429298, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 350 participants
- Enrollment target
Study Summary
In this randomized controlled trial, 2 mg intravenous (IV) hydromorphone will be more efficacious than usual care (usual care is analgesic management according to the judgment of the attending physician caring for that patient) in emergency department (ED) patients aged 21-64 years. The primary efficacy outcomes are the proportion of patients in each arm who choose to forgo additional pain medication in 30 minutes of entry into the study and the change in numerical rating scale (NRS) pain scores from baseline to 30 minutes post baseline.
Interventions
- DRUG Hydromorphone
- DRUG Usual care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01429298
The ClinicalTrials.gov registry entry for NCT01429298 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT01429298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01429298 about?
NCT01429298 is a clinical study titled "Comparing Intravenous Hydromorphone to Usual Care". In this randomized controlled trial, 2 mg intravenous (IV) hydromorphone will be more efficacious than usual care (usual care is analgesic management according to the judgment of the attending physician caring for that patient) in emergency department (ED) patients aged 21-64 years. The primary effi...
What is the current status of trial NCT01429298?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2010-03. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01429298?
The interventions under investigation include: Hydromorphone (DRUG), Usual care (DRUG).
Who is sponsoring clinical trial NCT01429298?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.